Maternal haemorrhage

British Journal of Anaesthesia

Volumn 103, Issue SUPPL.1, 2009, Pages

  Walfish, M ^a   Neuman, A ^a   Wlody, D ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Anaesthesia, obstetric; Anaesthetic techniques; Complications, haemorrhage; Uterus, blood flow

Indexed keywords

BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN;

FEMALE; HUMAN; PLACENTA DISORDER; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; UTERUS BLEEDING;

FACTOR VIIA; FEMALE; HUMANS; PLACENTA DISEASES; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS; RECOMBINANT PROTEINS; RISK FACTORS; UTERINE HEMORRHAGE;

EID: 77449149810     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep303     Document Type: Article

References (58)

1. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrollable postpartum haemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171: 694-700
2. American College of Obstetricians and Gynecologists. Postpartum, haemorrhage. Practice Bulletin No. 76. Obstet Gynecol 2006; 108: 1039-47
3. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105: 198-208
4. Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol 2009; 33: 88-95
5. Berg CJ, Harper MA, Atkinson SM, et al. Preventability of pregnancy-related deaths. Results of a state-wide review. Obstet Gynecol 2005; 106: 1228-34
6. Bonnar J. Massive obstetric haemorrhage. Baillieres Clin Obstet Gynaecol 2000; 14: 1-18
7. Bonner SM, Haynes SR, Ryall D. The anaesthetic management of caesarean section for placenta praevia: a questionnaire survey. Anaesthesia 1995; 50: 992-4
8. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13
9. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006; 113: 919-24
10. Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacologic and surgical therapy for primary postpartum haemorrhage. Curr Pharm Des 2005; 11: 759-73
11. Calleja-Agius J, Custo R, Brincat M, et al. Placental abruption and placenta praevia. Eur Clin Obstet Gynaecol 2006; 2: 121-7
12. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004; 104: 1005-10
13. Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance-United States, 1991-1999. Morb Mortal Weekly Rep 52: 1-8
14. Combs CA, Murphy EL, Laros RK, Jr. Factors associated with postpartum haemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 69-76
15. Confidential Enquiries into Maternal Deaths in the United Kingdom, 2003-2005. Available from http://www.cemach.org.uk. Accessed August 28, 2009
16. Deux JF, Bazot M, Leblanche AF, et al. Is selective embolisation of uterine arteries a safe alternative to hysterectomy in patients with postpartum haemorrhage? Am J Roentgenol 2001; 177: 145-9
17. Devine PC. Obstetric haemorrhage. Semin Perinatol 2009; 33: 76-80
18. Dildy GA. Postpartum haemorrhage: new management options. Clin Obstet Gynecol 2002; 45: 330-44
19. Dildy GA, III, Paine AR, George NC, et al. Estimating blood loss: can teaching significantly improve visual estimation? Obstet Gynecol 2004; 104: 601-6
20. Doumouchtsis SK, Papageoghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum haemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007; 62: 540-7
21. Doumouchtsis SK, Papageoghiou AT, Vernier C. Management of postpartum haemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol 2008; 87: 849-55
22. Drife J. Management of primary postpartum haemorrhage. Br J Obstet Gynaecol 1997; 104: 275-7
23. Gallos G, Redai I, Smiley R. The role of the anesthesiologist in management of obstetric hemorrhage. Semin Perinatol 2009; 33: 116-23
24. Glaze S, Ekwalanga P, Roberts G, et al. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol 2008; 111: 732-8
25. Hackethal A, Brueggmann D, Oehke F, Tinneberg HR, Zygmunt MT, Muenstedt K. Uterine compression U-sutures in primary postpartum haemorrhage after Cesarean section: fertility preservation with a simple and effective technique. Hum Reprod 2008; 23: 74-9
26. Hamm J, Russell Z, Botha T, et al. Buccal misoprostol to prevent haemorrhage at cesarean delivery: a randomized study. Am J Obstet Gynecol 2005; 192: 1404-6
27. Hansch E, Chitkara U, McaAlpine J, et al. Pelvic arterial embolisation for control obstetric haemorrhage: a five year experience. Am J Obstet Gynecol 1999; 180: 1454-60
28. Harber CR, Levy DM, Chidambaram S, Macpherson MB. Life-threatening bronchospasm after intramuscular carboprost for postpartum haemorrhage. BJOG 2007; 114: 366-8
29. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 106: 509-16
30. James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009; 201: 12e1-8
31. Kadir RA, Aledort LM. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol 2000; 22: 12-6
32. Karpati PC, Rossignol M, Pirot M, et al. High incidence of myocardial ischemia during postpartum haemorrhage. Anesthesiology 2004; 100: 30-6
33. Kim D, Baer SD. Up to date: interventional radiology in management of obstetrical and gynecological disorders. 2008. Available from uptodate.com. Accessed August 12
34. Knight M, UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. Br J Obstet Gynaecol 2007; 114: 1380-7
35. Mayer DC, Smith KA. Chestnut's Obstetric Anaesthesia Principles and Practice, 4th Edn. Missouri: Elsevier Mosby, 2009; 825-30
36. Mirza FD, Gaddipaty S. Obstetric emergencies. Semin Perinatol 2009; 33: 97-103
37. Munn MB, Owen J, Vincent R, et al. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol 2001; 98: 386-90
38. Nall KS, Feldman B. Postpartum myocardial infarction induced by methergine. Am J Emerg Med 1998; 16: 502-4
39. New York State Department of Health. Managing Haemorrhage Poster. NYS Safe Motherhood Initiative. Available from www.acog .org. Accessed August 26, 2009
40. O'Brien P, El-Refaey H, Gordon A, et al. Rectally administered misoprostol for the treatment of postpartum haemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998; 92: 212-4
41. Ojala K, Perala J, Kariniemi J. Arterial embolisation and prophylactic catheterization for the treatment for severe obstetric haemorrhage. Acta Obstet Gynecol Scand 2005; 84: 1075-80
42. Oleary JA. Uterine artery ligation in the control of postcesarean haemorrhage. J Reprod Med 1995; 40: 189
43. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006; 108: 1005-16
44. Padmanabhan A, Schwartz J, Spitalnik SL. Transfusion therapy in postpartum haemorrhage. Semin Perinatol 2009; 33: 124-7
45. Rebarber A, Lonser R, Jackson S, et al. The safety of intraoperative autologous blood collection and autotransfusion during cesarian section. Am J Obstet Gynecol 1998; 179: 715-20
46. Rouse DJ, Leindecker S, Landon M, et al. The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005; 193: 1056-60
47. Santrach PJ. Is cell salvage a safe technique for the obstetric patient? Con Soc Obstet Anaesth Perinatol Newsletter, Fall 2005; 7-9
48. Shah M, Wright JD. Surgical intervention in the management of postpartum haemorrhage. Semin Perinatol 2009; 33: 109-14
49. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226-32
50. Svanström MC, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth 2008; 100: 683-9
51. Usta IM, Hobeika EM, Musa AA, et al. Am J Obstet Gynecol 2005; 193: 1045-9
52. Walsh CA, Baxi LV. Rupture of the primigravid uterus: a review of the literature. Obstet Gynecol Surv 2007; 62: 327-34
53. Welsh A, McLintock C, Gatt S, et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008; 48: 12-6
54. World Health Organization. Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF, and UNFPA. Geneva: World Health Organization, 2004
55. World Health Organization. The World Health Report 2005: Make Every Mother and Child Count. Geneva, Switzerland: WHO Press, 2005; 62
56. World Health Organization. The prevention and management of postpartum haemorrhage. WHO Report of Technical Working Group. Geneva: World Health Organization, 1990
57. Yaegashi N, Miura M, Okamura K. Acute myocardial infarction associated with postpartum ergot alkaloid administration. Int J Gynaecol Obstet 1999; 64: 67-8
58. You WB, Zahn CM. Postpartum haemorrhage: abnormally adherent placenta, uterine inversion, and puerperal hematomas. Clin Obstet Gynecol 2006; 49: 184-97